Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial

By sjmartinez • December 16, 2022

Podolanczuk AJ, Kim JS, Cooper CB, Lasky JA, Murray S, Oldham JM, Raghu G, Flaherty KR, Spino C, Noth I, Martinez FJ; PRECISIONS Study Team. Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial. BMC Pulm Med. 2022 Dec 13;22(1):475. doi: 10.1186/s12890-022-02281-8. PMID: 36514019; PMCID: PMC9746571.

Tags: Clinical Trial, IPF, N-acetylcysteine, protocol, Publications, Pulmonary, Critical Care & Sleep Medicine

Progression-Free Survival in Metastatic Breast Cancer by Local Investigators vs Blinded Independent Central Review: A Systematic Review and Meta-Analysis

Ravani LV, Bagheri Z, Kalinsky K, Burstein HJ, Bardia A, Mouabbi JA, O'Regan R, Wander SA. Progression-Free Survival in Metastatic Breast Cancer by Local Investigators[...]

Cross-cohort analysis of expression and splicing quantitative trait loci in TOPMed

Orchard P, Blackwell TW, Kachuri L, Castaldi PJ, Cho MH, Christenson SA, Durda P, Gabriel S, Hersh CP, Huntsman S, Hwang S, Joehanes R, Johnson[...]

Chronological versus physiological age for 10-year survival estimation: a real-world healthsystem-wide cohort analysis

Justice AC, Tate JP, McGinnis KA, Torgersen JL, Braithwaite RS, Marconi VC, Goetz MB, Rodriguez-Barradas MC, Brown ST, Park L, Oursler KAK, Womack JA, Becker[...]